Report cover image

Global Labeled Nucleotides Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 102 Pages
SKU # APRC20548771

Description

Summary

According to APO Research, The global Labeled Nucleotides market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Labeled Nucleotides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Labeled Nucleotides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Labeled Nucleotides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Labeled Nucleotides include ThermoFisher Scientific, Nanjing BioTogether, F. Hoffmann-La Roche, Yumpu, Star Lake Bioscience, Promega Corporation, Meihua Group, Lallemand and Jena Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Labeled Nucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Labeled Nucleotides.
The Labeled Nucleotides market size, estimations, and forecasts are provided in terms of sales volume (k tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Labeled Nucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Labeled Nucleotides Segment by Company

ThermoFisher Scientific
Nanjing BioTogether
F. Hoffmann-La Roche
Yumpu
Star Lake Bioscience
Promega Corporation
Meihua Group
Lallemand
Jena Bioscience
DSM Nutritional Products
CJ CheilJedang Corporation
Biorigin
Agilent Technologies
Affymetrix
Labeled Nucleotides Segment by Type

Gene Chips & Microarrays
SNP by Pyrosequencing
TaqMan Allelic Discrimination
Labeled Nucleotides Segment by Application

Hospital Laboratories
Academic Research Laboratories
Reference Laboratories
Other Laboratories
Labeled Nucleotides Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Labeled Nucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Labeled Nucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Labeled Nucleotides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Labeled Nucleotides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Labeled Nucleotides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

102 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Labeled Nucleotides Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Labeled Nucleotides Sales Estimates and Forecasts (2020-2031)
1.3 Labeled Nucleotides Market by Type
1.3.1 Gene Chips & Microarrays
1.3.2 SNP by Pyrosequencing
1.3.3 TaqMan Allelic Discrimination
1.4 Global Labeled Nucleotides Market Size by Type
1.4.1 Global Labeled Nucleotides Market Size Overview by Type (2020-2031)
1.4.2 Global Labeled Nucleotides Historic Market Size Review by Type (2020-2025)
1.4.3 Global Labeled Nucleotides Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Labeled Nucleotides Sales Breakdown by Type (2020-2025)
1.5.2 Europe Labeled Nucleotides Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Labeled Nucleotides Sales Breakdown by Type (2020-2025)
1.5.4 South America Labeled Nucleotides Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Labeled Nucleotides Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Labeled Nucleotides Industry Trends
2.2 Labeled Nucleotides Industry Drivers
2.3 Labeled Nucleotides Industry Opportunities and Challenges
2.4 Labeled Nucleotides Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Labeled Nucleotides Revenue (2020-2025)
3.2 Global Top Players by Labeled Nucleotides Sales (2020-2025)
3.3 Global Top Players by Labeled Nucleotides Price (2020-2025)
3.4 Global Labeled Nucleotides Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Labeled Nucleotides Major Company Production Sites & Headquarters
3.6 Global Labeled Nucleotides Company, Product Type & Application
3.7 Global Labeled Nucleotides Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Labeled Nucleotides Market CR5 and HHI
3.8.2 Global Top 5 and 10 Labeled Nucleotides Players Market Share by Revenue in 2024
3.8.3 2023 Labeled Nucleotides Tier 1, Tier 2, and Tier 3
4 Labeled Nucleotides Regional Status and Outlook
4.1 Global Labeled Nucleotides Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Labeled Nucleotides Historic Market Size by Region
4.2.1 Global Labeled Nucleotides Sales in Volume by Region (2020-2025)
4.2.2 Global Labeled Nucleotides Sales in Value by Region (2020-2025)
4.2.3 Global Labeled Nucleotides Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Labeled Nucleotides Forecasted Market Size by Region
4.3.1 Global Labeled Nucleotides Sales in Volume by Region (2026-2031)
4.3.2 Global Labeled Nucleotides Sales in Value by Region (2026-2031)
4.3.3 Global Labeled Nucleotides Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Labeled Nucleotides by Application
5.1 Labeled Nucleotides Market by Application
5.1.1 Hospital Laboratories
5.1.2 Academic Research Laboratories
5.1.3 Reference Laboratories
5.1.4 Other Laboratories
5.2 Global Labeled Nucleotides Market Size by Application
5.2.1 Global Labeled Nucleotides Market Size Overview by Application (2020-2031)
5.2.2 Global Labeled Nucleotides Historic Market Size Review by Application (2020-2025)
5.2.3 Global Labeled Nucleotides Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Labeled Nucleotides Sales Breakdown by Application (2020-2025)
5.3.2 Europe Labeled Nucleotides Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Labeled Nucleotides Sales Breakdown by Application (2020-2025)
5.3.4 South America Labeled Nucleotides Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Labeled Nucleotides Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 ThermoFisher Scientific
6.1.1 ThermoFisher Scientific Comapny Information
6.1.2 ThermoFisher Scientific Business Overview
6.1.3 ThermoFisher Scientific Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ThermoFisher Scientific Labeled Nucleotides Product Portfolio
6.1.5 ThermoFisher Scientific Recent Developments
6.2 Nanjing BioTogether
6.2.1 Nanjing BioTogether Comapny Information
6.2.2 Nanjing BioTogether Business Overview
6.2.3 Nanjing BioTogether Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nanjing BioTogether Labeled Nucleotides Product Portfolio
6.2.5 Nanjing BioTogether Recent Developments
6.3 F. Hoffmann-La Roche
6.3.1 F. Hoffmann-La Roche Comapny Information
6.3.2 F. Hoffmann-La Roche Business Overview
6.3.3 F. Hoffmann-La Roche Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.3.4 F. Hoffmann-La Roche Labeled Nucleotides Product Portfolio
6.3.5 F. Hoffmann-La Roche Recent Developments
6.4 Yumpu
6.4.1 Yumpu Comapny Information
6.4.2 Yumpu Business Overview
6.4.3 Yumpu Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Yumpu Labeled Nucleotides Product Portfolio
6.4.5 Yumpu Recent Developments
6.5 Star Lake Bioscience
6.5.1 Star Lake Bioscience Comapny Information
6.5.2 Star Lake Bioscience Business Overview
6.5.3 Star Lake Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Star Lake Bioscience Labeled Nucleotides Product Portfolio
6.5.5 Star Lake Bioscience Recent Developments
6.6 Promega Corporation
6.6.1 Promega Corporation Comapny Information
6.6.2 Promega Corporation Business Overview
6.6.3 Promega Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Promega Corporation Labeled Nucleotides Product Portfolio
6.6.5 Promega Corporation Recent Developments
6.7 Meihua Group
6.7.1 Meihua Group Comapny Information
6.7.2 Meihua Group Business Overview
6.7.3 Meihua Group Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Meihua Group Labeled Nucleotides Product Portfolio
6.7.5 Meihua Group Recent Developments
6.8 Lallemand
6.8.1 Lallemand Comapny Information
6.8.2 Lallemand Business Overview
6.8.3 Lallemand Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lallemand Labeled Nucleotides Product Portfolio
6.8.5 Lallemand Recent Developments
6.9 Jena Bioscience
6.9.1 Jena Bioscience Comapny Information
6.9.2 Jena Bioscience Business Overview
6.9.3 Jena Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jena Bioscience Labeled Nucleotides Product Portfolio
6.9.5 Jena Bioscience Recent Developments
6.10 DSM Nutritional Products
6.10.1 DSM Nutritional Products Comapny Information
6.10.2 DSM Nutritional Products Business Overview
6.10.3 DSM Nutritional Products Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DSM Nutritional Products Labeled Nucleotides Product Portfolio
6.10.5 DSM Nutritional Products Recent Developments
6.11 CJ CheilJedang Corporation
6.11.1 CJ CheilJedang Corporation Comapny Information
6.11.2 CJ CheilJedang Corporation Business Overview
6.11.3 CJ CheilJedang Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CJ CheilJedang Corporation Labeled Nucleotides Product Portfolio
6.11.5 CJ CheilJedang Corporation Recent Developments
6.12 Biorigin
6.12.1 Biorigin Comapny Information
6.12.2 Biorigin Business Overview
6.12.3 Biorigin Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biorigin Labeled Nucleotides Product Portfolio
6.12.5 Biorigin Recent Developments
6.13 Agilent Technologies
6.13.1 Agilent Technologies Comapny Information
6.13.2 Agilent Technologies Business Overview
6.13.3 Agilent Technologies Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Agilent Technologies Labeled Nucleotides Product Portfolio
6.13.5 Agilent Technologies Recent Developments
6.14 Affymetrix
6.14.1 Affymetrix Comapny Information
6.14.2 Affymetrix Business Overview
6.14.3 Affymetrix Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Affymetrix Labeled Nucleotides Product Portfolio
6.14.5 Affymetrix Recent Developments
7 North America by Country
7.1 North America Labeled Nucleotides Sales by Country
7.1.1 North America Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Labeled Nucleotides Sales by Country (2020-2025)
7.1.3 North America Labeled Nucleotides Sales Forecast by Country (2026-2031)
7.2 North America Labeled Nucleotides Market Size by Country
7.2.1 North America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Labeled Nucleotides Market Size by Country (2020-2025)
7.2.3 North America Labeled Nucleotides Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Labeled Nucleotides Sales by Country
8.1.1 Europe Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Labeled Nucleotides Sales by Country (2020-2025)
8.1.3 Europe Labeled Nucleotides Sales Forecast by Country (2026-2031)
8.2 Europe Labeled Nucleotides Market Size by Country
8.2.1 Europe Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Labeled Nucleotides Market Size by Country (2020-2025)
8.2.3 Europe Labeled Nucleotides Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Labeled Nucleotides Sales by Country
9.1.1 Asia-Pacific Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Labeled Nucleotides Sales by Country (2020-2025)
9.1.3 Asia-Pacific Labeled Nucleotides Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Labeled Nucleotides Market Size by Country
9.2.1 Asia-Pacific Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Labeled Nucleotides Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Labeled Nucleotides Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Labeled Nucleotides Sales by Country
10.1.1 South America Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Labeled Nucleotides Sales by Country (2020-2025)
10.1.3 South America Labeled Nucleotides Sales Forecast by Country (2026-2031)
10.2 South America Labeled Nucleotides Market Size by Country
10.2.1 South America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Labeled Nucleotides Market Size by Country (2020-2025)
10.2.3 South America Labeled Nucleotides Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Labeled Nucleotides Sales by Country
11.1.1 Middle East and Africa Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Labeled Nucleotides Sales by Country (2020-2025)
11.1.3 Middle East and Africa Labeled Nucleotides Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Labeled Nucleotides Market Size by Country
11.2.1 Middle East and Africa Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Labeled Nucleotides Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Labeled Nucleotides Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Labeled Nucleotides Value Chain Analysis
12.1.1 Labeled Nucleotides Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Labeled Nucleotides Production Mode & Process
12.2 Labeled Nucleotides Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Labeled Nucleotides Distributors
12.2.3 Labeled Nucleotides Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.